ArticleThe Journal of pharmacology and experimental therapeutics2016

Class I Histone Deacetylase Inhibition for the Treatment of Sustained Atrial Fibrillation.

Mitsuru Seki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.